
CAS: 319460-94-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | AG-13958 REF: 54-BUP02372CAS: 319460-94-1 | 99.83% | 960.00 €~1,699.00 € | Mon 21 Apr 25 |
![]() | AG-13958 REF: 7W-GW6755CAS: 319460-94-1 | - - - | 656.00 €~1,851.00 € | Thu 24 Apr 25 |
![]() | AG-13958 REF: TM-T7493CAS: 319460-94-1 | 99.40% | 97.00 €~1,254.00 € | Thu 24 Apr 25 |
![]() | AG 13958 REF: 3D-FA103515CAS: 319460-94-1 | Min. 95% | - - - | Discontinued product |

Ref: 54-BUP02372
25mg | 960.00 € | ||
50mg | 1,277.00 € | ||
100mg | 1,699.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

Ref: 7W-GW6755
1mg | 656.00 € | ||
5mg | 1,216.00 € | ||
10mg | 1,851.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025

AG-13958
CAS:319460-94-1
AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular …
Formula:
C26H22FN7O
Purity:
99.40%
Color and Shape:
Solid
Molecular weight:
467.5
Ref: TM-T7493
1mg | 97.00 € | ||
5mg | 264.00 € | ||
10mg | 406.00 € | ||
25mg | 655.00 € | ||
50mg | 944.00 € | ||
100mg | 1,254.00 € | ||
1mL*10mM (DMSO) | 274.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025

AG 13958
CAS:319460-94-1
AG 13958 is a biological product that is used to treat age-related macular degeneration. It …
Formula:
C26H22FN7O
Purity:
Min. 95%
Molecular weight:
467.5 g/mol
Ref: 3D-FA103515
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |